Signals

WHWK

37 in-universe funds with a nonzero position in WHWK within the trailing 4 quarters, as of 2025Q2

Catalyst Timeline merged from Insider (Form 4), 8-K and Ownership/dilution filings already on file -- not a live news feed Full insider history

DateTypeWhat happened
2026-09-10 8-K Item(s) 5.02, 9.01
2026-08-06 8-K Item(s) 2.02, 9.01
2026-06-12 8-K Item(s) 5.07
2026-05-29 Ownership Dilution filing by Whitehawk Therapeutics, Inc. (S-3)
2026-05-21 8-K Item(s) 8.01, 9.01
2026-05-14 Insider Dalal Anupam acquired via award ($4,999,999)
2026-05-14 Insider Dugan Margaret (Chief Medical Officer) acquired via award ($74,997)
2026-05-14 Insider Lennon David James (CHIEF EXECUTIVE OFFICER) acquired via award ($200,002)
2026-05-14 Insider BALL BRYAN (See remarks) acquired via award ($199,998)
2026-05-14 Insider Castelein Caley acquired via award ($1,000,000)
2026-05-14 Insider Giacobello Scott M. (CHIEF FINANCIAL OFFICER) acquired via award ($149,999)
2026-05-13 8-K Item(s) 1.01, 3.02, 7.01, 9.01
2026-05-07 8-K Item(s) 2.02, 9.01
2026-04-16 Insider Giacobello Scott M. (CHIEF FINANCIAL OFFICER) disposed via sale ($584,808)
2026-04-15 Insider Giacobello Scott M. (CHIEF FINANCIAL OFFICER) disposed via sale ($297,220)
2026-04-14 Insider BALL BRYAN (See remarks) disposed via sale ($336,554)
2026-04-13 Insider BALL BRYAN (See remarks) disposed via sale ($91,306)
2026-03-12 8-K Item(s) 2.02, 9.01
2025-11-06 8-K Item(s) 2.02, 9.01
2025-08-07 8-K Item(s) 2.02, 9.01
2025-06-13 8-K Item(s) 5.07
2025-04-25 Ownership Dilution filing by Whitehawk Therapeutics, Inc. (424B5)
2025-03-31 Ownership Dilution filing by Whitehawk Therapeutics, Inc. (S-3)
2025-03-18 Ownership Dilution filing by Whitehawk Therapeutics, Inc. (D)
2024-05-03 Ownership Dilution filing by Whitehawk Therapeutics, Inc. (424B5)
2024-02-12 Ownership Dilution filing by Whitehawk Therapeutics, Inc. (S-3)
2022-10-26 Ownership Dilution filing by Whitehawk Therapeutics, Inc. (S-3)
2022-10-11 Ownership Dilution filing by Whitehawk Therapeutics, Inc. (D)
2022-03-21 Ownership Dilution filing by Whitehawk Therapeutics, Inc. (424B5)
2022-03-17 Ownership Dilution filing by Whitehawk Therapeutics, Inc. (424B5)

Flow ranking

Rank#1647
Score / z0.001 / -0.02
Consensus15.77 over 25 funds
Momentumno 12m return

Price & positioning

224 cached closes, trailing year
Drawdownno history
Short interest+116% / 3.3d ⚡

Forensics

Clean as of 2026Q2
Accrual ratio-0.011
F-score
M-score
Net issuance-54.2%

Insider

Score+0.00
Buys / cluster sells0 / 0
DateInsiderCodeValue
2026-05-14 Dalal Anupam A $4,999,999
2026-05-14 Dugan Margaret A $74,997
2026-05-14 Lennon David James A $200,002
2026-05-14 BALL BRYAN A $199,998
2026-05-14 Castelein Caley A $1,000,000
2026-05-14 Giacobello Scott M. A $149,999
2026-04-16 Giacobello Scott M. S $584,808
2026-04-15 Giacobello Scott M. S $297,220
2026-04-14 BALL BRYAN S $336,554
2026-04-13 BALL BRYAN S $91,306
Showing the 10 most recent.

8-K events

Negative / total0 / 2
FiledFormItems
2026-09-10 8-K 5.02, 9.01
2026-08-06 8-K 2.02, 9.01
2026-06-12 8-K 5.07
2026-05-21 8-K 8.01, 9.01
2026-05-13 8-K 1.01, 3.02, 7.01, 9.01
2026-05-07 8-K 2.02, 9.01
2026-03-12 8-K 2.02, 9.01
2025-11-06 8-K 2.02, 9.01
2025-08-07 8-K 2.02, 9.01
2025-06-13 8-K 5.07
Showing the 10 most recent.

Ownership

13D / 13G / dilution0 / 0 / 1
FiledFormFiler
2026-05-29 S-3 Whitehawk Therapeutics, Inc.
2025-04-25 424B5 Whitehawk Therapeutics, Inc.
2025-03-31 S-3 Whitehawk Therapeutics, Inc.
2025-03-18 D Whitehawk Therapeutics, Inc.
2024-05-03 424B5 Whitehawk Therapeutics, Inc.
2024-02-12 S-3 Whitehawk Therapeutics, Inc.
2022-10-26 S-3 Whitehawk Therapeutics, Inc.
2022-10-11 D Whitehawk Therapeutics, Inc.
2022-03-21 424B5 Whitehawk Therapeutics, Inc.
2022-03-17 424B5 Whitehawk Therapeutics, Inc.
Showing the 10 most recent.

LLM reads

Ticker Evalpending
Quarter
Fund AUM ($M)
Fund Positions
Quarters Held

Fund holders

Fund Quality Q Positions Value ($M) % of Fund AUM Qtrs Held Δ 1Q Δ 2Q Δ 3Q Δ 4Q
QVT Financial LP CIK 0001290162 0.874 72 8.2 1.1% 1 +1.1 pp +1.1 pp +1.1 pp +1.1 pp
ORBIMED ADVISORS LLC CIK 0001055951 0.515 121 7.8 0.2% 1 +0.2 pp +0.2 pp +0.2 pp +0.2 pp
MONTANOVA CAPITAL, LLC CIK 0001569064 0.534 95 6.9 0.3% 1 +0.3 pp +0.3 pp +0.3 pp +0.3 pp
ACUTA CAPITAL PARTNERS, LLC CIK 0001582844 0.146 23 6.4 8.9% 1 +8.9 pp +8.9 pp +8.9 pp +8.9 pp
Avoro Capital Advisors LLC CIK 0001633313 0.835 26 5.3 0.1% 1 +0.1 pp +0.1 pp +0.1 pp +0.1 pp
Siren, L.L.C. CIK 0002005245 0.594 115 3.9 0.2% 1 +0.2 pp +0.2 pp +0.2 pp +0.2 pp
Yu Fan CIK 0001668029 0.533 8 3.9 5.3% 1 +5.3 pp +5.3 pp +5.3 pp +5.3 pp
VANGUARD GROUP INC CIK 0000102909 0.000 0 2.5 0.0% 1 +0.0 pp +0.0 pp +0.0 pp +0.0 pp
ACORN CAPITAL ADVISORS, LLC CIK 0002054410 0.437 20 2.1 1.4% 2 -0.0 pp +1.4 pp +1.4 pp +1.4 pp
EcoR1 Capital, LLC CIK 0001587114 0.612 31 2.0 0.1% 1 +0.1 pp +0.1 pp +0.1 pp +0.1 pp
Ally Bridge Group (NY) LLC CIK 0001822947 0.014 23 1.5 1.3% 1 +1.3 pp +1.3 pp +1.3 pp +1.3 pp
RENAISSANCE TECHNOLOGIES LLC CIK 0001037389 0.399 3140 0.9 0.0% 1 +0.0 pp +0.0 pp +0.0 pp +0.0 pp
GEODE CAPITAL MANAGEMENT, LLC CIK 0001214717 0.990 4447 0.7 0.0% 1 +0.0 pp +0.0 pp +0.0 pp +0.0 pp
BRIDGEWAY CAPITAL MANAGEMENT, LLC CIK 0001107261 0.377 1233 0.6 0.0% 1 +0.0 pp +0.0 pp +0.0 pp +0.0 pp
BlackRock, Inc. (BLK) CIK 0002012383 0.995 5652 0.6 0.0% 1 +0.0 pp +0.0 pp +0.0 pp +0.0 pp
Peapod Lane Capital LLC CIK 0002050979 0.076 61 0.5 0.5% 1 +0.5 pp +0.5 pp +0.5 pp +0.5 pp
JANE STREET GROUP, LLC CIK 0001595888 0.450 5522 0.2 0.0% 1 +0.0 pp +0.0 pp +0.0 pp +0.0 pp
NORTHERN TRUST CORP (NTRS, NTRSO) CIK 0000073124 0.983 4440 0.2 0.0% 1 +0.0 pp +0.0 pp +0.0 pp +0.0 pp
DIMENSIONAL FUND ADVISORS LP CIK 0000354204 0.963 3221 0.1 0.0% 1 +0.0 pp +0.0 pp +0.0 pp +0.0 pp
STATE STREET CORP (STT, STT-PG) CIK 0000093751 0.993 4261 0.1 0.0% 1 +0.0 pp +0.0 pp +0.0 pp +0.0 pp
Squarepoint Ops LLC CIK 0001642575 0.419 2729 0.1 0.0% 1 +0.0 pp +0.0 pp +0.0 pp +0.0 pp
CITADEL ADVISORS LLC CIK 0001423053 0.482 6351 0.1 0.0% 1 +0.0 pp +0.0 pp +0.0 pp +0.0 pp
UBS Group AG (UBS) CIK 0001610520 0.954 9044 0.0 0.0% 1 +0.0 pp +0.0 pp +0.0 pp +0.0 pp
OSAIC HOLDINGS, INC. CIK 0001677044 0.882 7705 0.0 0.0% 2 +0.0 pp +0.0 pp +0.0 pp +0.0 pp
Tower Research Capital LLC (TRC) CIK 0001533421 0.051 5180 0.0 0.0% 1 +0.0 pp +0.0 pp +0.0 pp +0.0 pp
US BANCORP \DE\ (USB, USB-PA, USB-PH, USB-PP, USB-PQ, USB-PR, USB-PS) CIK 0000036104 0.946 4139 0.0 0.0% 1 +0.0 pp +0.0 pp +0.0 pp +0.0 pp
MORGAN STANLEY (MS, MS-PA, MS-PE, MS-PF, MS-PI, MS-PK, MS-PL, MS-PO, MS-PP, MS-PQ) CIK 0000895421 0.985 8402 0.0 0.0% 3 -0.0 pp -0.0 pp +0.0 pp +0.0 pp
BARTLETT & CO. WEALTH MANAGEMENT LLC CIK 0002010186 0.825 1334 0.0 0.0% 1 +0.0 pp +0.0 pp +0.0 pp +0.0 pp
JPMORGAN CHASE & CO (JPM, AMJB, VYLD, JPM-PC, JPM-PD, JPM-PJ, JPM-PK, JPM-PL, JPM-PM) CIK 0000019617 0.981 6818 0.0 0.0% 1 +0.0 pp +0.0 pp +0.0 pp +0.0 pp
BANK OF AMERICA CORP /DE/ (BAC, BAC-PB, BAC-PE, BAC-PK, BAC-PL, BAC-PM, BAC-PN, BAC-PO, BAC-PP, BAC-PQ, BAC-PS, BML-PG, BML-PL) CIK 0000070858 0.982 5665 0.0 0.0% 2 +0.0 pp +0.0 pp +0.0 pp +0.0 pp
Russell Investments Group, Ltd. CIK 0001692234 0.905 4383 0.0 0.0% 1 +0.0 pp +0.0 pp +0.0 pp +0.0 pp
FEDERATED HERMES, INC. (FHI) CIK 0001056288 0.708 2038 0.0 0.0% 1 +0.0 pp +0.0 pp +0.0 pp +0.0 pp
TD Waterhouse Canada Inc. CIK 0001999606 0.893 2405 0.0 0.0% 1 +0.0 pp +0.0 pp +0.0 pp +0.0 pp
BNP PARIBAS FINANCIAL MARKETS CIK 0001166588 0.856 5105 0.0 0.0% 1 +0.0 pp +0.0 pp +0.0 pp +0.0 pp
SBI Securities Co., Ltd. CIK 0001851815 0.645 4072 0.0 0.0% 1 +0.0 pp +0.0 pp +0.0 pp +0.0 pp
Parallel Advisors, LLC CIK 0001690010 0.782 3893 0.0 0.0% 1 +0.0 pp +0.0 pp +0.0 pp +0.0 pp
Semmax Financial Advisors Inc. CIK 0001767301 0.227 431 0.0 0.0% 0 -0.0 pp +0.0 pp +0.0 pp +0.0 pp
Value and % of AUM are this fund's own disclosed long-equity book (13F does not report true firm AUM). Positions is the fund's total position count (all tickers, not just WHWK). Qtrs Held counts distinct quarters this fund has actually held WHWK (weight > 0), across every period we've rescored. Fund AUM and Positions filters apply to the fund's whole book, not its WHWK position size. Δ columns are the percentage-point change in WHWK's weight within each fund's book vs. the trailing 1/2/3/4 quarters (2025Q1 / 2024Q4 / 2024Q3 / 2024Q2) — a fund not yet holding it that far back is treated as 0%. Only in-universe (quality-scored) funds are shown, matching the Signals-tab methodology.
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short. JSON: /api/signals · /api/funds · /api/status